Juola P, Miettunen J, Salo H, Murray G K, Ahmed A O, Veijola J, Isohanni M, Jääskeläinen E
Research Unit of Clinical Neuroscience, Department of Psychiatry, University of Oulu, P.O. BOX 5000, FIN-90014, Finland.
Medical Research Center Oulu, University of Oulu and Oulu University Hospital, P.O. BOX 5000, FIN-90014, Finland.
Schizophr Res Cogn. 2015 Sep 21;2(3):113-119. doi: 10.1016/j.scog.2015.07.001. eCollection 2015 Sep.
The purpose of this study was to study neurocognitive performance as a predictor of outcomes in midlife schizophrenia. There is a lack of studies with unselected samples and a long follow-up. The study is based on the prospective, unselected population-based Northern Finland Birth Cohort 1966. The study includes 43 individuals with schizophrenia and 73 controls, whose neurocognitive performance was assessed twice, at 34 and 43 years. At both time points we used identical neurocognitive tests to assess verbal and visual memory and executive functions. Our main aim was to analyse neurocognitive performance at 34 years as a predictor of clinical, vocational and global outcomes at 43 years. Additionally, the analysis addressed cross-sectional associations between cognitive performance and clinical, vocational and global measures at 43 years. The assessment of outcomes was performed in the schizophrenia group only. In the longitudinal analysis poorer visual memory predicted poorer vocational outcome and poorer long-term verbal memory predicted poorer global outcome. In the cross-sectional analysis poorer visual memory and lower composite score of neurocognition were associated with poorer global outcome. No individual neurocognitive test or the composite score of these predicted remission. These data indicate that neurocognition, especially memory function, is an important determinant of long-term functional outcome in midlife schizophrenia.
本研究的目的是探讨神经认知表现能否作为中年精神分裂症患者预后的预测指标。目前缺乏针对未筛选样本且随访时间长的研究。本研究基于前瞻性、未筛选的芬兰北部1966年出生队列人群。该研究纳入了43例精神分裂症患者和73名对照者,在他们34岁和43岁时对其神经认知表现进行了两次评估。在两个时间点,我们均使用相同的神经认知测试来评估言语和视觉记忆以及执行功能。我们的主要目的是分析34岁时的神经认知表现,作为43岁时临床、职业和整体预后的预测指标。此外,该分析还探讨了43岁时认知表现与临床、职业和整体指标之间的横断面关联。仅在精神分裂症组中进行了预后评估。在纵向分析中,较差的视觉记忆预示着较差的职业预后,较差的长期言语记忆预示着较差的整体预后。在横断面分析中,较差的视觉记忆和较低的神经认知综合评分与较差的整体预后相关。没有任何一项单独的神经认知测试或这些测试的综合评分能够预测缓解情况。这些数据表明,神经认知,尤其是记忆功能,是中年精神分裂症患者长期功能预后的重要决定因素。